Evidence map›Paper›PMID 35204161›Full record

ArticleAntioxidants (Basel, Switzerland)2022

Nitric Oxide Resistance in

Nathalia Pinho, Ana Cristina Bombaça, Jacek R Wiśniewski, Geovane Dias-Lopes, Leonardo Saboia-Vahia, Elisa Cupolillo, José Batista de Jesus, Roque P de Almeida, Gabriel Padrón, Rubem Menna-Barreto and 1 more

Open access · goldAbstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Heme metabolism in Strigomonas culicis: Implications of HThe Journal of biological chemistry · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Nathalia PinhoLaboratório de Pesquisa em Leishmanioses, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-360, RJ, Brazil.
Ana Cristina BombaçaLaboratório de Biologia Celular, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-360, RJ, Brazil.
Jacek R WiśniewskiBiochemical Proteomics Group, Department of Proteomics and Signal Transduction, Max-Planck-Institute of Biochemistry, 82152 Planegg, Germany.
Geovane Dias-LopesLaboratório de Biologia Molecular e Doenças Endêmicas, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-360, RJ, Brazil.ORCID 0000-0003-4448-1398
Leonardo Saboia-VahiaLaboratório de Pesquisa em Leishmanioses, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-360, RJ, Brazil.
Elisa CupolilloLaboratório de Pesquisa em Leishmanioses, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-360, RJ, Brazil.ORCID 0000-0002-0620-3250
José Batista de JesusDepartamento de Medicina, Universidade Federal de São João Del Rei, São João del Rei 35501-296, MG, Brazil.
Roque P de AlmeidaDepartment of Medicine, Hospital Universitário, EBSERH, Universidade Federal de Sergipe, Aracaju 49100-000, SE, Brazil.
Gabriel PadrónLaboratório de Pesquisa em Leishmanioses, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-360, RJ, Brazil.ORCID 0000-0003-3308-2471
Rubem Menna-BarretoLaboratório de Biologia Celular, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-360, RJ, Brazil.
Patricia CuervoLaboratório de Pesquisa em Leishmanioses, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-360, RJ, Brazil.ORCID 0000-0002-6245-4185
Fundação Oswaldo Cruz · BRFederal University of São João del-Rei · BRMax Planck Institute of Biochemistry · DEUniversidade Federal de Sergipe · BR

Funding

Coordenação de Aperfeicoamento de Pessoal de Nível Superior Finance Code 001 - P.C. - Process No. 88887.374332/2019-00Coordenação de Aperfeicoamento de Pessoal de Nível Superior G.P. Process No. 0344141Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro N.P. - TCT No. E-26/202.464/2017Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro P.C. - JCNE E-26/203.253/2017National Council for Scientific and Technological Development PQ-P.C. Process No. 305796/2017-8 and 312573/2020-0National Council for Scientific and Technological Development R.P.A. - PQ Process No. 309776/2018-0National Council for Scientific and Technological Development Universal grant No. 423300/2018-0
6 · The paper itself

Abstract

In American Tegumentary Leishmaniasis production of cytokines, reactive oxygen species and nitric oxide (NO) by host macrophages normally lead to parasite death. However, some

Indexed as

American Tegumentary Leishmaniasis (ATL)FASPglutathione metabolismglycolysisLeishmania braziliensismass spectrometrynitric oxide resistancenitrosative stressquantitative proteomicsreactive nitrogen speciesreactive oxygen species

Identifiers

PMID35204161
PMCPMC8868067
OpenAlexW4210407646

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.